A.M. Freydiere, F. Parant, C. Chaux, Y. Gille. ABSTRACT Objectives: While Albicans ID2 (bioMérieux) detects only hexosaminidase enzymatic activity for.

Slides:



Advertisements
Similar presentations
Are there changes in candidemia epidemiology and susceptibility profile in 7 Belgian hospitals after a 5 year period? C. Van Laer 1*,2, K. Lagrou 2, P.
Advertisements

Evaluation of the influence of different antifungal clinical breapkpoints to susceptibility testing of candidemia isolates from 7 Belgian hospitals C.
IDENTIFIKASI BAKTERI OLEHSUDRAJAT FMIPA UNMUL 2009.
In vitro susceptibility testing to caspofungin and anidulafungin of Candida spp. isolated from blood cultures in 7 Belgian hospitals C. Van Laer 1*2,2.
Printed by Comparison of Primary Care and Clinical Laboratory Methods for the Diagnosis of Bacterial Vaginosis and Yeast Vaginitis.
NEW Product MAY 2006 STREPTO B ID NEW chromogenic media available ! STREPTO B ID NEW PRODUCT in the bMx offer SECOND in the NEW PREVENTION range dedicated.
Evaluation of the FUNGIFAST ® AFG yeast antifungal susceptibility test : comparison with EUCAST and the E-Test method INTERNAL STUDY - (ELITECH GROUP -
The usefulness of direct sensitivity testing of urine samples containing coliform bacteria (determined microscopically) has been established previously.
Isolation and Identification of Staphylococci
Improved growth of Vancomycin resistant Enterococci on ChromID™ VRE agar by incubation in 5% CO 2 Varuna Navaratne, Sydney Bell and Jeanette Pham SEALS.
A.M. Freydiere 1 and R. Robert 2 1 Hôpital Debrousse, Hospices Civils de Lyon, 2 Parasitologie-Mycologie, Angers, France Rapid Candida glabrata identification.
AM. Freydiere 1, M. Bes 2, MA. Charveriat 3, A. Carricajo 3, C. Ploton 1 1 Hôpital Debrousse, Hospices Civils de Lyon, 2 CNR Toxémies à Staphylocoques,
A.M. Freydiere 1, T. Goyard 1, C. Ploton 1, D. Thouvenot 2, A. Rousson 1 and F. Vandenesch 1 1 Hôpital Debrousse, Hospices.
PHT 381 Lab# 4. A Culture medium:- ❊ An artificial preparation which contains the essential elements and nutrients needed by the m.o to grow. (most.
General Microbiology Laboratory Biochemical Tests.
Mycology – Yeast Student Lab Division of Medical Technology Carol Larson MSEd, MT(ASCP)
Mycology.
Comparison of the Diagnostic Value of the Standard Tube Agglutination Test and the ELISA IgG and IgM in Patients with Brucellosis Presented by Dr. Md.
PHT 381 Lab# 4. A Culture medium:- ❊ An artificial preparation which contains the essential elements and nutrients needed by the m.o to grow. (most.
Citizen Water Quality Monitoring: Bacterial testing using defined substrates David W. Buckalew Dept. of Natural Sciences Kathleen M. Register Clean Virginia.
Mannitol Salt Agar-Cefoxitin Combination as a Screening Medium for MRSA SMYTH, RW and KAHLMETER, G Dept. of Clinical Microbiology, Central Hospital, S-351.
UNIVERSITY OF COLORADO SCHOOL OF MEDICINE DEPARTMENT OF PATHOLOGY RESIDENCY TRAINING PROGRAM MICROBIOLOGY Case Studies: Beta Hemolytic Streptococci ANSWERS.
The Effects of Antibiotics on Yeast Survivorship
IN THE NAME OF ALLAH ALMIGHTY THE MOST COMPASSIONATE THE MERCIFUL.
Temistocle Despina Luciana. Short background The Candida gender is represented by dimorphic-like fungi can shift from yeast to pseudomycelial state, depending.
AbstractAbstract IntroductionIntroduction MethodsMethods ResultsResults Candida albicans accounted for 45.2%, Candida tropicalis 22.3%, Candida glabrata.
NCCLS (1997) Approved standard M27-A. Rex JH et al. Clin Infect Dis (1997) 24: Pfaller M. A., et al. Diagn Microbiol Infect Dis (1999); 35:19-25.
Panbio Dengue ELISAs.
LAB 4: ASEPTIC TECHNIQUE AND ISOLATION OF BACTERIA
University of Tabuk Faculty of Applied Medical Science
Correlation of Neo-Sensitabs on Three Media with NCCLS Reference Disk Diffusion and Broth Microdilution Methods for Testing the Susceptibility of Candida.
CANDIDA & CRYTOCOCCUS Prepared by: Miss Norzawani Jaffar Bsc (Hons) Biomedical Sciences, UKM Lecture 15.
In vitro antifungal activity of voriconazole and fluconazole against Candida spp. isolated from oral fluid Author: Tatarici Andreea Co-authors: Lecturer.
BIBLE PAPER 26 AUG 2015 CANDIDA GLABRATA ESOPHAGITIS: ARE WE SEEING THE EMERGENCE OF A NEW AZOLE-RESISTANT PATHOGEN? WILSON A, DELPORT J, PONICH T. INT.
UNIVERSITY OF COLORADO SCHOOL OF MEDICINE DEPARTMENT OF PATHOLOGY RESIDENCY TRAINING PROGRAM MICROBIOLOGY Case Studies: Beta Hemolytic Streptococci.
Urinary Tract Infection Department of Microbiology
RESULTS INTRODUCTION METHODS CONCLUSION  Since the early 90’s Enterococcus faecium resistant to Glycopeptides (GRE) have emerged in several French hospitals.
Bacterial identification
Microbiology / Lab. 8. o Culture (Growth) Media I.What is a medium (plural media)? II.What is culture medium? III.What is meant by Inoculation of Media?
COAGULASE AND AMYLASE TEST
Things to Do Today Observe Unknown gm (-) results Start Urinalysis Start gm (+) ID –Check for hemolysis –Catalase test –Coagulase test –Direct stain colonies.
Detection, Prophylaxis and Treatment of Bacterial Infection.
Biochemical Activities of Microorganisms Part (1)
Microorganism Identification Process
Laboratory Diagnosis Chapter 8. APPROACH TO LABORATORY DIAGNOSIS ● The laboratory diagnosis of infectious diseases involves two main approaches, the bacteriologic.
CONCLUSIONS Amended Abstract Detection of GBS Directly from ESwab Collected Samples Using the BD MAX™ GBS Assay Suzane Silbert, Talita T. Rocchetti, Alicia.
Stool Culture, E. coli O157:H7
Candidiasis A primary or secondary mycotic infection caused by members of the genus Candida. The clinical manifestations may be acute, subacute or chronic.
Microbial Biotechnology Reem Alsharief Lab 3. General Methods of Isolation and selection of Microorganism Microbial isolation: To separate (a pure strain)
Risk Factors for Candida dubliniensis Bloodstream Infections Katherine Veltman, B.S., Peggy L. Carver, Pharm.D, FCCP The University of Michigan Health.
PHARMACEUTICAL MICROBIOLOGY -I PHT 226 Dr. Rasheeda Hamid Abdalla Assistant Professor hotmail.com.
‘A COMPARISON OF THREE RAPID DIAGNOSTIC TECHNIQUES FOR THE IDENTIFICATION OF YEASTS DIRECT FROM BLOOD CULTURE' Rebecca Gorton Centre for Clinical Microbiology.
Urinary Tract Infection Department of Microbiology
Abstract Identification of uncommon species of the clinical isolates of the yeasts by ITS-sequencing Hossein Khodadadi 1, Ladan Karimi 2, Hossein Mirhendi.
INTRODUCTION AND OBJECTIVES DISCUSSION AND CONCLUSION
Comprised of Blood Agar and CHROMagarTM Orientation using WASPLabTM
Comparative Methods of Speciation of Candida Isolated from Patients with Vulvovaginitis in Ekpoma and Environs, Nigeria. N. J. Inyang1, I. B. Enweani2,
Urinary Tract Infection Department of Microbiology
Biochemical Tests.
Tools of the Laboratory: Methods for Culturing of Microorganisms
Lab diagnosis of fungal infection
Jane L. Burns, Jean-Marc Rolain  Journal of Cystic Fibrosis 
The Effects of Antibiotics on Yeast Survivorship
Efficacy of Chromogenic Candida Agar for isolation and presumptive identification of pathogenic yeast species  E. Ghelardi, G. Pichierri, B. Castagna,
Microorganism Identification Process
The Six “I’s” of Microbiology
DIDESSE E.1, DUPREZ JN.2, MAINIL J.2, THIRY D.2
San Franciscan chicken
Amoeba culturing methods for recovering amoeba-resisting microorganisms (ARMs). Amoeba culturing methods for recovering amoeba-resisting microorganisms.
General schematic for the identification of bacteria and yeast by MALDI-TOF MS using the intact-cell method. General schematic for the identification of.
Presentation transcript:

A.M. Freydiere, F. Parant, C. Chaux, Y. Gille. ABSTRACT Objectives: While Albicans ID2 (bioMérieux) detects only hexosaminidase enzymatic activity for the identification of Candida albicans (blue colonies), Candida ID agar medium (bioMérieux) detects a second enzymatic activity (patented) for the discrimination of different yeast species (pink colonies). This study comparatively accesses the performance of Candida ID and Albicans ID2 agar media for the identification of Candida albicans as well as yeast isolation and discrimination. Method: 139 yeast stock strains belonging to 16 species and 131 miscellaneous clinical specimens, were streaked identically on both media. Growth and aspect of colonies were monitored after 24, 48, and 72 hrs of incubation at 36°C. All isolates were identified using conventional mycological methods including the Bichrolatex albicans test and the ID32C system. Results: In term of yeasts growth, Candida ID and Albicans ID2 agar media showed similar performance. The second substrate included in the Candida ID agar did not allow the identification of any additional Candida species since 39 of 43 C. tropicalis, 5 of 5 C. kefyr, 2 of 5 C. sphaerica, 2 of 2 C. lusitaniae, 1 of 2 Saccharomyces cerevisiae and 1 of 1 C. utilis strains tested yielded pink colonies. However 5 stock C. tropicalis strains showing positive hexosaminidase activity on Albicans ID2 after 48 hrs of incubation, yielded pink colonies on Candida ID. These 5 false-C. albicans blue colonies on Albicans ID2 were thus clearly distinguished from true C. albicans strains on Candida ID. Moreover in 3 out of the 22 clinical samples yielding several yeast strains, an additional Candida strain (1 C. tropicalis, 1 C. kefyr and 1 C. parapsilosis strain) was detected on Candida ID due to the pink-colored colonies. Conclusion: Compared to Albicans ID2, Candida ID improved specificity for C. albicans identification and differentiation of colonies in mixed fungal populations. 10th ECCMID, STOCKHOLM, May 28-31, 2000 P-278 INTRODUCTION Candida ID and Albicans ID2 (bioMérieux, France) are ready-to-use media which, use the hydrolyzing capacity of a hexosaminidase substrate to color Candida albicans colonies blue. In addition Candida ID contains a specific inhibitor of the C. tropicalis hexosaminidase enzyme and a second enzymatic substrate yielding rose-colored colonies (patented). 139 yeast stock strains encompassing 16 species and notably 43 C. tropicalis strains were subcultured on Sabouraud glucose agar at 30°C for 18 to 24 hrs, then streaked identically onto each of the two media. 131 clinical samples (59 stool specimens, 28 sputum specimens, 25 genital specimens, 8 urine specimens, 11 wound specimens) collected from hospitalized patients were tested. Each non-fluid specimen was suspended in 0.85% physiological saline; 0.01 ml of this suspension or fluid specimen was inoculated onto Candida ID and Albicans ID2 plates. For the two media, all the morphologically different colonies were identified using conventional mycological methods including the Bichrolatex Albicans (Fumouze Diagnostics, France) and when required, assimilation pattern with ID 32C (bioMerieux, France). Reading of the plates and interpretation of the results were conducted after incubation for 24, 48, and 72 hrs at 36°C. MATERIAL AND METHODS Laboratoire de Microbiologie, Hôpital de l’Antiquaille, Hospices Civils de Lyon, Lyon cedex 5, France. Like the Germ Tube test and the other chromogenic media (9) Candida ID did not allow the differentiation of C. dubliniensis from C. albicans. As C. dubliniensis strains are known to be more resistant to azole antifungal agents, in some clinical situations [e.g., oral specimens from human immunodeficiency virus (HIV)-infected and AIDS patients], it may be important to differentiate the two species. In that cases, Candida strains yielding blue or green colonies on chromogenic media should be further identified by means of commercial yeast identification systems. Since, recently, (i) Pincus et al. (10) comparing API 20C AUX, ID 32 C, RapID Yeast Plus, Vitek YBC and Vitek 2 ID-YST systems showed that the rapidity of the assimilation of Methyl D-glucose (MDG), Trehalose (TRE), and Xylose (XYL) achieved with the different commercial sytems allowed the differentiation of C. dubliniensis from C. albicans and (ii) Gales et al. (11) showed that lack of growth at 45°C and a negative XYL test with either API 20C AUX or Vitek yeast identification panel provide a presumptive identification of C. dubliniensis. II) Results with 131 clinical specimens  Yeast isolation and discrimination Of 131 clinical specimens tested a total of 65 yielded one or several yeast strains or a mixture of yeast and bacterial strains. (43 monomicrobial cultures and 22 mixed cultures). RESULTS AND DISCUSSION Chromogenic media have been shown to allow an easier discrimination of Candida species colonies in mixed yeast populations than does Sabouraud agar, as well as rapid identification of Candida species directly on the primary isolation medium (1-8). These media may avoid or diminish the need for subculture and further biochemical tests, and considerably simplify the identification procedure. Furthermore, if more organisms can be identified within 24hrs rather than 48hrs, this reduction in turnaround time can be translated directly into a more rapid transition from empirical to directed antifungal therapy. Candida ID (bioMérieux, Marcy L'Etoile, France) is a new version of Albicans ID2, for the direct identification of Candida albicans. Compared to the previous formula Candida ID contains two chromogenic substrates and a specific inhibitor of the C. tropicalis hexosaminidase enzyme. Thus it is intended to improve differentiation of mixed cultures and specificity for direct identification of C. albicans while maintaining the same growth performance and the same C. albicans identification rate. The aim of this work is to compare the two formula (i) with 139 stock strains (ii) 131 miscellaneous clinical specimens evaluated in a true clinical laboratory context. Table 1 : Identity and colony color of 139 yeast strains grown 48hrs at 36°C on Albicans ID2 and on Candida ID Table 2: Fungi detected from 65 clinical specimens after incubation for 48 hrs at 36°C on Albicans ID2, and Candida ID On Candida ID, due to the pink-colored colonies, in 3/22 clinical specimens yielding several fungi, an additional Candida strain (1 C. tropicalis, 1 C. kefyr and 1 C. parapsilosis) was detected.  Identification of C. albicans. Table 3:Candida albicans identification with Albicans ID2 and Candida ID after incubation for 24hrs and 48hrs at 36°C CONCLUSION 1. Baumgartner C, Freydière AM, Gille Y. Direct identification and recognition of yeast species from clinical material by using Albicans ID and CHROMagar Candida plates. J Clin Microbiol 1996, 34: De Champs C, Lebeau B, Grillot R, Ambroise-Thomas R. Evaluation of Albicans ID plates. J Clin Microbiol 1995, 33: Lipperheide V, Andraka L, Ponton J, Quindos G. Evaluation of the Albicans ID plate method for the rapid identification of Candida albicans. Mycoses 1993, 36: Rousselle P, Freydière AM, Couillerot PJ, de Montclos H, Gille Y. Rapid identification of Candida albicans by using Albicans ID and Fluoroplate agar plates. J Clin Microbiol 1994, 32: Willinger B, Manafi M, Rotter ML. Comparison of rapid methods using fluorogenic-chromogenic assays for detecting Candida albicans. Letters in Applied Microbiology 1994, 18: Freydière AM, Buchaille L, Gille Y. Comparison of three media for direct identification and discrimination of Candida species in clinical specimens. Eur J Clin Microbiol Infect Dis 1997; 16: Hoppe JE, Frey P. Evaluation of six commercial tests and the germ-tube test for presumptive identification of Candida albicans. Eur J Clin Microbiol Infect Dis 1999; 18: Freydière AM., Guinet R. Rapid methods for identification of the most frequent clinical yeasts. Rev Iberoam Micol 1997; 14: Tintelnot K, Haase G, Seibold M, et al. Evaluation of phenotypic markers for selection and identification of C. dubliniensis. J Clin Microbiol 2000; 38: Pincus DH, Coleman DC, Pruitt WR, et al. Rapid identification of Candida dubliniensis with commercial yeast identification systems. J Clin Microbiol 1999; 37: Gales AC, Pfaller MA, Houston AK, et al. Identification of C. dubliniensis based on temperature and utilization of xylose and a-Methyl-D-glucoside as determined with the API 20C AUX and Vitek YBC systems. J Clin Microbiol 1999; 37: REFERENCES Compared to the previous formula, Candida ID plates demonstrated: similar performance in term of yeasts growth and a lower anti-bacterial selectivity. a slightly higher detection rate due to a better differentiation of colonies in mixed cultures. an improved specificity for C. albicans identification. CANDIDA ID, A NEW CHROMOGENIC MEDIUM COMPARED TO ALBICANS ID2  Anti-bacterial selectivity On Candida ID, 5 bacterial strains: 2 Pseudomonas aeruginosa strains (isolated from 1 wound specimen and 1 stool specimen) and 3 Streptococcus spp. strains (isolated from 2 genital specimens and 1 stool specimen) grew. On Albicans ID2, none bacterial strain grew. On Candida ID, the additional substrate enabled more specific identification of C. albicans since 5/43 C. tropicalis strains, showing positive hexosaminidase activity on Albicans ID2 after 48hrs of incubation, yielded pink or white colonies on Candida ID. These 5 false-C.albicans blue colonies on Albicans ID2 were thus clearly distinguished from true C. albicans on Candida ID. However, the additional substrate did not allow identification of any additional Candida species since 39 of 43 C. tropicalis, 5 of 5 C. kefyr, 2 of 5 C. sphaerica, 2 of 2 C. lusitaniae, 1 of 2 Saccharomyces cerevisiae and 1 of 1 C. utilis strains tested yielded pink colonies. C. glabrata, C. krusei, C. parapsilosis and other C. species, less commonly encountered, yielded white colonies. I) Results with 139 yeast stock strains The sensitivity for growth and specific pigmentation was established on the total number of C. albicans strains isolated on at least one medium. None false positive C. albicans strain was found on both Albicans ID2 and Candida ID.